Abstract
The design and synthesis of 4-(2-adamantyl)phenylalkylamines 1-4 are described and their antiproliferative activity against four different tumor cell lines is reported.
Keywords: C-2 substituted adamantane, 4-(2-adamantyl)phenylalkylamines, antiproliferative activity.
Letters in Organic Chemistry
Title:Synthesis and Cytotoxicity of 4-(2-Adamantyl)phenylalkylamines
Volume: 12 Issue: 5
Author(s): Ioannis Papanastasiou, Stefanos Riganas, George B. Foscolos, Andrew Tsotinis, Samar A. Akhtar, Mohsin A. Khan, Khondaker M. Rahman and David E. Thursto
Affiliation:
Keywords: C-2 substituted adamantane, 4-(2-adamantyl)phenylalkylamines, antiproliferative activity.
Abstract: The design and synthesis of 4-(2-adamantyl)phenylalkylamines 1-4 are described and their antiproliferative activity against four different tumor cell lines is reported.
Export Options
About this article
Cite this article as:
Papanastasiou Ioannis, Riganas Stefanos, B. Foscolos George, Tsotinis Andrew, A. Akhtar Samar, A. Khan Mohsin, M. Rahman Khondaker and E. Thursto David, Synthesis and Cytotoxicity of 4-(2-Adamantyl)phenylalkylamines, Letters in Organic Chemistry 2015; 12 (5) . https://dx.doi.org/10.2174/157017861205150509202419
DOI https://dx.doi.org/10.2174/157017861205150509202419 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Loxapine P-glycoprotein Interactions In Vitro
Drug Metabolism Letters Role of NF-κB in the Regulation of Cytochrome P450 Enzymes
Current Drug Metabolism Imidazoles and Benzimidazoles as Tubulin-Modulators for Anti-Cancer Therapy
Current Medicinal Chemistry Anticancer Potential of Calli <i>Versus</i> Seedling Extracts Derived from <i>Rosmarinus officinalis</i> and <i>Coleus hybridus</i>
Current Pharmaceutical Biotechnology Roles of Secreted Phospholipases A<sub>2</sub> in the Mammalian Immune System
Protein & Peptide Letters Ethical Implications of Pharmacogenetics: Shaping the Future of the Field
Current Pharmacogenomics Editorial (Thematic Issue: The Effects of Anticancer Agents on Cell Apoptosis and on the Expression of Cancer - Related Genes)
Anti-Cancer Agents in Medicinal Chemistry Inhibition of Anti-Apoptotic Bcl-2 Family Proteins by Natural Polyphenols New Avenues for Cancer Chemoprevention and Chemotherapy
Current Pharmaceutical Design Suicide Gene Therapy Against Malignant Gliomas by the Local Delivery of Genetically Engineered Umbilical Cord Mesenchymal Stem Cells as Cellular Vehicles
Current Gene Therapy Berberine Administration in Treatment of Colitis: A Review
Current Drug Targets Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor Progression
Current Medicinal Chemistry Reflecting Back to Bring Nitric Oxide Research to the Laboratory
Current Medicinal Chemistry Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease
Current Pharmaceutical Design HDAC Inhibitors-New Generation of Target Specific Treatment
Mini-Reviews in Medicinal Chemistry Protein Kinases as Drug Targets in Human and Animal Diseases
Current Enzyme Inhibition Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?
Current Cancer Drug Targets Smart Phones As a Viable Data Collection Tool in Low-resource Settings: Case Study of Rwandan Community Health Workers
Neuroscience and Biomedical Engineering (Discontinued) Defensin Participation in Innate and Adaptive Immunity
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Medicinal Chemistry Stereoselective Pharmacodynamics and Pharmacokinetics of Proton Pump Inhibitors
Current Drug Metabolism